{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:14:03Z","timestamp":1761066843214,"version":"build-2065373602"},"reference-count":116,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3364,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p>Management of human immunodeficiency virus (HIV) has become increasingly complex since the introduction of highly active antiretroviral therapy (HAART). Patients with HIV have become exposed to an increasing array of drugs to treat HIV, prevent opportunistic infections and immune dysfunction, and manage comorbid illnesses and therapeutic complications. Hepatic complications have become common and may lead to discontinuation of treatment and significant morbidity. Up to 90% of patients with acquired immunodeficiency syndrome (AIDS) receive at least one drug that can cause hepatotoxicity. Clinicians treating patients with HIV frequently face difficulty distinguishing abnormal liver transaminase levels and toxicities in patients receiving several drugs. Some potential causes of hepatic dysfunction are viral infections, alcohol and substance abuse, and hepatotoxic drugs such as HAART. Recent reports have focused on the hepatotoxicity of HAART and the role of hepatitis viruses to the exclusion of many other agents prescribed for patients with HIV. Many of the common antibiotics, antifungals, antivirals, and ancillary agents prescribed for patients with HIV are independently associated with hepatotoxicity. Clinicians should be aware of the potential non\u2010antiretroviral hepatotoxic agents that are frequently administered in HIV management.<\/jats:p>","DOI":"10.1592\/phco.22.16.1468.33702","type":"journal-article","created":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T10:45:31Z","timestamp":1086086731000},"page":"1468-1478","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Looking Beyond Highly Active Antiretroviral Therapy: Drug\u2010Related Hepatotoxicity in Patients with Human Immunodeficiency Virus Infection"],"prefix":"10.1002","volume":"22","author":[{"given":"Robert","family":"Orenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nickolaos","family":"Tsogas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/339042"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/341084"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30319"},{"key":"e_1_2_1_6_2","first-page":"118","article-title":"High hepatotoxicity rate seen among HAART patients","volume":"16","author":"Reisler K","year":"2001","journal-title":"Aids Alert"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200108150-00002"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107060-00007"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03806.x"},{"key":"e_1_2_1_10_2","first-page":"1153","article-title":"Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures worldwide, 1997\u20132000","volume":"49","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/317449"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.74"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012220-00011"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00311-7"},{"key":"e_1_2_1_15_2","first-page":"1","article-title":"Guidelines for using antiretroviral agents among HIV\u2010infected adults and adolescents: recommendations of the panel on clinical practices for treatment of HIV. MMWR Morb Mortal Wkly Rep (no","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"RR-7)"},{"issue":"1","key":"e_1_2_1_16_2","first-page":"S529","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"30","year":"2000","journal-title":"Clin Infect Dis"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(21)00234-X"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402801009"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300407"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.9.1799"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430080133"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00095.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203193261203"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260202"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203263261301"},{"key":"e_1_2_1_26_2","first-page":"50","volume-title":"Med Lett Drugs Ther","author":"Abramowicz M","year":"1990"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400050150032"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80081-0"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80082-2"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420010136016"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92676-7"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90141-4"},{"key":"e_1_2_1_33_2","first-page":"165","article-title":"Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration","volume":"91","author":"Guillaume MP","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92120-7"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(92)91346-D"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/516975"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0016-5085(84)80021-9","article-title":"Hepatic injury associated with ketoconazole therapy: analysis of 33 cases","volume":"86","author":"Lewis JH","year":"1984","journal-title":"Gastroenterology"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6569.419"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90519-3"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(86)80495-0"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.6.636"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.1984.00350170237037","article-title":"Fatal hepatitis associated with ketoconazole therapy","volume":"144","author":"Duarte PA","year":"1984","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70214-M"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90527-A"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199710010-00005"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200201243460403"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1086\/324620"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199308050-00003"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1086\/313475"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.4.1073"},{"key":"e_1_2_1_51_2","first-page":"394","article-title":"Fulminant hepatic failure associated with clarithromycin","volume":"91","author":"Shaheen N","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410030074010"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90401-I"},{"key":"e_1_2_1_54_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.1994.03520070055038","article-title":"Epidemiology of tuberculosis in the United States, 1985\u20131992","volume":"272","author":"Cantwell MF","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_1_55_2","first-page":"1978","article-title":"Hepatotoxicity from isoniazid and rifampin in inner\u2010city AIDS patients","volume":"90","author":"Ozick LA","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.6.9711039"},{"key":"e_1_2_1_57_2","first-page":"573","article-title":"Six\u2010months isoniazid\u2010rifampin therapy for pulmonary tuberculosis: report of a U.S. Public Health Service cooperative trial","volume":"129","author":"Snider DE","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(81)90046-2"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.6.7952606"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200201040-00010"},{"key":"e_1_2_1_61_2","first-page":"991","article-title":"Isoniazid\u2010related hepatitis: a U.S. Public Health Service cooperative surveillance study","volume":"117","author":"Kopanoff DE","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_62_2","first-page":"461","article-title":"Predisposing factors in hepatitis induced by isoniazid\u2010rifampin treatment of tuberculosis","volume":"118","author":"Gronhagen\u2010Riska C","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.3.387"},{"key":"e_1_2_1_64_2","first-page":"1056","article-title":"Pyrazinamide fulminant hepatitis: an old hepatotoxin strikes again","volume":"7","author":"Danan G","year":"1981","journal-title":"Lancet"},{"volume-title":"Core curriculum on tuberculosis","year":"1994","author":"National Center for Prevention Services Division of Tuberculosis Elimination","key":"e_1_2_1_65_2"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.1014"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1086\/314037"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.11.1445"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00014"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06532-X"},{"key":"e_1_2_1_71_2","first-page":"733","article-title":"Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society\/CDC recommendations: United States 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1086\/313771"},{"key":"e_1_2_1_73_2","first-page":"586","article-title":"In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro\u2010piperidyl rifamycin","volume":"126","author":"Woodley CL","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291202"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/141.4_Pt_1.821"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.3.594"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120223"},{"key":"e_1_2_1_78_2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0016-5085(81)90146-3","article-title":"Terminal hepatic failure following a small dose of trimethoprim\u2010sulfamethoxazole","volume":"80","author":"Ransohoff DF","year":"1981","journal-title":"Gastro- enterology"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90346-Z"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.144.8.1691"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1995.tb04378.x"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528209182041"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-5-663"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-4-495"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-1-37"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/9.Supplement_2.S184"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-4-280"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.122"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.854"},{"key":"e_1_2_1_90_2","first-page":"1068","volume":"151","author":"Montgomery AB","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-8-606"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199411000-00018"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370010173037"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.1.165"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710153171602"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.1.91"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90086-9"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198406143102401"},{"key":"e_1_2_1_99_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17843286.1999.11754203","article-title":"Valaciclovir\u2010induced hepatitis","volume":"54","author":"Renkes P","year":"1999","journal-title":"Acta Clin Belg"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603273141301"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070020849025"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(87)33536-5"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1987.tb03529.x"},{"key":"e_1_2_1_104_2","first-page":"432","article-title":"Possible ganciclovir\u2010induced hepatotoxicity in patients with AIDS","volume":"11","author":"Figge H","year":"1992","journal-title":"Clin Pharm"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549209052604"},{"key":"e_1_2_1_106_2","unstructured":"RomeuJ SirenaG RegoMJ.Cumulative risk for developing hyperlipidemia in HIV\u2010infected patients treated with protease inhibitors [abstr]. Presented at the 39th interscience conference on antimicrobial agents and chemotherapy San Francisco CA September 2629 1999."},{"key":"e_1_2_1_107_2","first-page":"1216","article-title":"Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the adult AIDS clinical trial group cardiovascular disease focus group","volume":"31","author":"Dube MP","year":"2001","journal-title":"Clin Infect Dis"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161020-00005"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00946-2"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.13.1066.35033"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199606001-00008"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-1-199807010-00005"},{"key":"e_1_2_1_113_2","first-page":"1","volume-title":"Hepatic effects associated with the clinical use of 17\u2010alkylated anabolic\u2010androgenic steroids","author":"Zimmerman H","year":"1999"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462011916893"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040579"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259912"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80070-9"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.22.16.1468.33702","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.22.16.1468.33702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:37:29Z","timestamp":1761064649000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.22.16.1468.33702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":116,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1592\/phco.22.16.1468.33702"],"URL":"https:\/\/doi.org\/10.1592\/phco.22.16.1468.33702","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}